Evidence map›Paper›PMID 38731473›Full record

ArticleMolecules (Basel, Switzerland)2024

Chalkophomycin Biosynthesis Revealing Unique Enzyme Architecture for a Hybrid Nonribosomal Peptide Synthetase and Polyketide Synthase.

Long Yang, Liwei Yi, Bang Gong, Lili Chen, Miao Li, Xiangcheng Zhu, Yanwen Duan, Yong Huang

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Copper-chelating natural products.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2025
    Review
  2. Review
  3. Elucidation of Chalkophomycin Biosynthesis RevealsJournal of the American Chemical Society · 2024
    Article
  4. Elucidation of chalkophomycin biosynthesis revealsbioRxiv : the preprint server for biology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Long YangDepartment of Immunology, School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China.
Liwei YiXiangya International Academy of Translational Medicine, Central South University, Changsha 410013, China.ORCID 0000-0001-6314-3277
Bang GongXiangya International Academy of Translational Medicine, Central South University, Changsha 410013, China.
Lili ChenHefei Comprehensive National Science Center, Institute of Health and Medicine, Hefei 230093, China.
Miao LiXiangya International Academy of Translational Medicine, Central South University, Changsha 410013, China.
Xiangcheng ZhuXiangya International Academy of Translational Medicine, Central South University, Changsha 410013, China.
Yanwen DuanXiangya International Academy of Translational Medicine, Central South University, Changsha 410013, China.
Yong HuangDepartment of Immunology, School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China.

Funding

Chinese Ministry of Education 111 Project BP0820034Hunan Provincial Natural Science Foundation of China 2022JJ40408National Natural Science Foundation of China 82204256National Natural Science Foundation of China 82373772
6 · The paper itself

Abstract

Chalkophomycin is a novel chalkophore with antibiotic activities isolated from

Indexed as

Multigene FamilyPeptide SynthasesPolyketide SynthasesStreptomycesBacterial ProteinsBacterial Proteinsnon-ribosomal peptide synthasePeptide SynthasesPolyketide Synthaseschain release mechanismchalkophorecopperhybrid NRPS/PKSpeptidereductase domain (R0)

Identifiers

PMID38731473
PMCPMC11085572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.